Novocure launches pivotal ovarian cancer trial

Novocure launches pivotal ovarian cancer trial

Source: 
Drug Delivery Business News
snippet: 

Novocure (NSDQ:NVCR) said today that it kicked off a Phase 3 pivotal trial testing its Tumor Treating Fields therapy combined with paclitaxel in people with recurrent, platinum-resistant ovarian cancer.